Advances in diabetic erectile dysfunction.
- Author:
Shu-Yan HUANG
1
;
Shu CHEN
;
Yi-Ping FENG
Author Information
1. Department of Gerontology, Second Affiliated Hospital of Guangzhou Medical College, Guangzhou, Guangdong 510260, China.
- Publication Type:Journal Article
- MeSH:
Animals;
Diabetes Complications;
epidemiology;
Diabetes Mellitus, Type 2;
epidemiology;
Erectile Dysfunction;
epidemiology;
pathology;
therapy;
Humans;
Male;
Rabbits;
Rats
- From:
National Journal of Andrology
2006;12(2):178-182
- CountryChina
- Language:Chinese
-
Abstract:
Erectile dysfunction is common complication of diabetes mellitus. The incidence of diabetes mellitus induced erectile dysfunction (DMED) is 20% - 75%. DMED appears to be due to vascular-neuropathic and corpus cavernosum smooth muscular damage. To control blood glucose, blood pressure and blood lipids is the basis of DMED therapy. In 50% of the patients with DMED, the phosphodiesterase 5 inhibitors is effective, while intracavernous pharmacotherapy is effective for more than 90%. Penile prosthesis implantation continues to be the treatment of choice in case of other therapy failure.
